Herzig S
Joint Research Division Molecular Metabolic Control, German Cancer Research Center, University of Heidelberg, University Hospital Heidelberg, Germany.
Exp Clin Endocrinol Diabetes. 2012 Apr;120(4):202-4. doi: 10.1055/s-0032-1304568. Epub 2012 Mar 8.
Whereas many studies have implicated metabolic liver dysfunction as a causative factor for obesity-related type 2 diabetes and the Metabolic Syndrome, its role as a long-term complication of diabetic metabolism is still mostly unexplored.In contrast to the well-described late diabetic micro- and macro-vascular complications in response to hyperglycemic conditions such as nephro- and retinopathy as well as atherosclerosis, only recent studies have highlighted disturbances of liver function as a novel aspect of diabetic late complications that may substantially impact the overall disease outcome and determine mortality rates in diabetic subjects. Here we will discuss recent developments in this area, particularly focusing on transcriptional regulators of hepatic dysfunction as a long-term consequence of established diabetes.
尽管许多研究认为代谢性肝功能障碍是肥胖相关2型糖尿病和代谢综合征的致病因素,但其作为糖尿病代谢长期并发症的作用仍大多未被探索。与因高血糖状况(如肾病、视网膜病变以及动脉粥样硬化)导致的已被充分描述的糖尿病晚期微血管和大血管并发症不同,直到最近才有研究强调肝功能紊乱是糖尿病晚期并发症的一个新方面,这可能会对整体疾病结局产生重大影响,并决定糖尿病患者的死亡率。在此,我们将讨论该领域的最新进展,尤其关注作为已确诊糖尿病的长期后果的肝功能障碍的转录调节因子。